Ditchcarbon
  • Customers
  1. Organizations
  2. Generation Bio Co.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 10 days ago

Generation Bio Co.

Company website

Generation Bio Co., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative gene therapies. Founded in 2016, the company has rapidly advanced its proprietary gene delivery platform, which aims to provide durable and potentially curative treatments for genetic diseases. With a strong emphasis on innovation, Generation Bio's core offerings include its unique non-viral gene therapy solutions, designed to overcome the limitations of traditional viral vectors. This approach positions the company at the forefront of the gene therapy industry, enabling it to address a wide range of genetic disorders. Notable achievements include significant funding rounds and strategic partnerships that have bolstered its market presence. As a leader in the biotechnology sector, Generation Bio is committed to advancing the future of medicine through its cutting-edge research and development initiatives.

DitchCarbon Score

How does Generation Bio Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Generation Bio Co.'s score of 29 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Generation Bio Co.'s reported carbon emissions

Generation Bio Co., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year. However, the company has set ambitious climate commitments aimed at achieving net-zero emissions. Generation Bio has outlined long-term targets to reach carbon neutrality in its operations by 2032 for both Scope 1 and Scope 2 emissions. These commitments reflect a growing trend within the industry to address climate change proactively. While specific reduction percentages have not been disclosed, the company's initiatives align with broader industry standards and expectations for sustainability. As part of its climate strategy, Generation Bio is committed to monitoring and reporting its progress towards these goals, ensuring transparency and accountability in its environmental impact. Overall, Generation Bio Co. is positioning itself as a responsible player in the biotechnology sector, with a clear focus on reducing its carbon footprint and contributing to global climate efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Generation Bio Co.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Generation Bio Co. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Generation Bio Co. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

CRISPR Therapeutics AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Genscript Biotech Corporation

CN
•
Research and development services (73)
Updated 9 days ago

Ansa Biotechnologies, Inc.

US
•
Health and social work services (85)
Updated 8 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250916.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy